In STGD1; also found in a patient with chorioretinal atrophy; reduced ATP-binding capacity; moderately decreases solubility; loss of cytoplasmic vesicle localization; decreases ATPase activity between 50% and 80%; decreases modestly N-Ret-PE-stimulated ATPase.
Attributes | Values |
---|---|
type | |
comment |
|
seeAlso | |
described by | |
has related | |
uniprot:core/range | |
uniprot:core/substitution |
|
is topic of | |
is object of | |
is uniprot:core/annotation of |